Statistics at a Glance

At a Glance

Estimated New Cases in 2022 99,780

% of All New Cancer Cases 5.2%

Estimated Deaths in 2022 7,650

% of All Cancer Deaths 1.3%

5-Year
Relative Survival

93.7% 2012–2018
Year Rate of New Cases — SEER 8 Rate of New Cases — SEER 12 Death Rate — U.S. 5-Year Relative Survival — SEER 8
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 8.78 8.56 - - 2.07 2.18 82.54% 81.29%
1976 8.84 9.00 - - 2.24 2.22 83.80% 81.90%
1977 9.65 9.46 - - 2.27 2.25 82.65% 82.51%
1978 9.64 9.94 - - 2.31 2.29 82.77% 83.09%
1979 10.20 10.45 - - 2.42 2.33 83.45% 83.65%
1980 11.09 10.99 - - 2.34 2.37 84.83% 84.20%
1981 11.68 11.55 - - 2.43 2.41 80.89% 84.73%
1982 11.58 11.87 - - 2.46 2.45 84.37% 85.25%
1983 11.90 12.20 - - 2.48 2.49 84.94% 85.75%
1984 12.10 12.54 - - 2.53 2.53 85.39% 86.23%
1985 13.59 12.89 - - 2.56 2.57 87.19% 86.70%
1986 13.64 13.24 - - 2.59 2.61 88.37% 87.15%
1987 14.44 13.61 - - 2.65 2.65 87.72% 87.59%
1988 13.59 13.99 - - 2.65 2.70 88.94% 88.02%
1989 14.40 14.38 - - 2.69 2.70 88.19% 88.43%
1990 14.46 14.78 - - 2.75 2.70 89.06% 88.83%
1991 15.28 15.19 - - 2.71 2.70 89.95% 89.22%
1992 15.54 15.61 14.57 14.68 2.71 2.70 88.66% 89.59%
1993 15.27 16.04 14.14 15.04 2.71 2.70 90.18% 89.95%
1994 16.32 16.49 15.13 15.41 2.66 2.70 88.95% 90.30%
1995 17.17 16.94 16.24 15.78 2.70 2.70 90.30% 90.64%
1996 18.01 17.41 16.87 16.17 2.80 2.70 92.27% 90.96%
1997 18.39 17.90 17.14 16.56 2.73 2.70 89.99% 91.28%
1998 18.18 18.39 16.87 16.97 2.75 2.70 91.04% 91.59%
1999 18.69 18.90 17.50 17.38 2.63 2.70 92.12% 91.88%
2000 19.79 19.43 18.06 17.80 2.66 2.70 92.52% 92.17%
2001 20.14 19.97 18.61 18.24 2.66 2.70 92.29% 92.44%
2002 19.60 20.52 17.97 18.68 2.61 2.70 92.96% 92.71%
2003 19.98 21.09 18.14 19.14 2.67 2.70 93.12% 92.97%
2004 21.64 21.68 19.43 19.61 2.67 2.70 93.29% 93.21%
2005 23.48 22.28 20.84 20.08 2.76 2.70 93.46% 93.45%
2006 23.42 22.90 20.75 20.57 2.74 2.70 93.63% 93.69%
2007 22.99 23.53 20.75 21.07 2.68 2.70 93.96% 93.91%
2008 24.38 24.18 21.66 21.30 2.69 2.70 94.11% 94.13%
2009 24.53 24.47 21.39 21.53 2.81 2.70 93.88% 94.33%
2010 25.46 24.75 22.24 21.76 2.74 2.70 94.59% 94.54%
2011 24.16 25.04 21.08 22.00 2.69 2.71 94.41% 94.73%
2012 24.04 25.34 21.28 22.23 2.66 2.71 95.56% 94.92%
2013 25.33 25.63 22.32 22.47 2.67 2.71 96.28% 95.10%
2014 26.74 25.93 23.63 22.71 2.57 2.54 96.23% 95.28%
2015 27.14 26.24 23.76 22.96 2.41 2.38 - 95.44%
2016 26.91 26.54 23.63 23.20 2.17 2.23 - 95.61%
2017 26.90 26.85 23.43 23.45 2.09 2.09 - 95.76%
2018 26.48 27.17 22.92 23.70 2.09 2.06 - 95.92%
2019 27.47 27.49 23.91 23.96 2.01 2.03 - 96.06%
2020 - - - - 2.02 2.01 - 96.20%

New cases come from SEER 12. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.

New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.


Rate of New Cases and Deaths per 100,000: The rate of new cases of melanoma of the skin was 21.5 per 100,000 men and women per year. The death rate was 2.1 per 100,000 men and women per year. These rates are age-adjusted and based on 2015–2019 cases and 2016–2020 deaths.

Lifetime Risk of Developing Cancer: Approximately 2.1 percent of men and women will be diagnosed with melanoma of the skin at some point during their lifetime, based on 2017–2019 data.

Prevalence of This Cancer: In 2019, there were an estimated 1,361,282 people living with melanoma of the skin in the United States.

Did You Know? Video Series

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Melanoma of the Skin?

Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

93.7%

5-Year
Relative Survival

93.7%

Based on data from SEER 17 2012–2018. Gray figures represent those who have died from melanoma of the skin. Green figures represent those who have survived 5 years or more.

Survival by Stage

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier melanoma of the skin is caught, the better chance a person has of surviving five years after being diagnosed. For melanoma of the skin, 81.6% are diagnosed at the local stage. The 5-year relative survival for localized melanoma of the skin is 99.5%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Melanoma of the Skin
Stage Percent of Cases 5-Year Relative Survival
Localized
Confined to Primary Site
82% 99.5%
Regional
Spread to Regional Lymph Nodes
9% 70.6%
Distant
Cancer Has Metastasized
4% 31.9%
Unknown
Unstaged
6% 90.2%

SEER 17 2012–2018, All Races, Both Sexes by SEER Combined Summary Stage

New Cases and Deaths

How Common Is This Cancer?

Compared to other cancers, melanoma of the skin is fairly common.

Rank Common Types of Cancer Estimated New
Cases 2022
Estimated
Deaths 2022
1. Breast Cancer (Female) 287,850 43,250
2. Prostate Cancer 268,490 34,500
3. Lung and Bronchus Cancer 236,740 130,180
4. Colorectal Cancer 151,030 52,580
5. Melanoma of the Skin 99,780 7,650
6. Bladder Cancer 81,180 17,100
7. Non-Hodgkin Lymphoma 80,470 20,250
8. Kidney and Renal Pelvis Cancer 79,000 13,920
9. Uterine Cancer 65,950 12,550
10. Pancreatic Cancer 62,210 49,830

Melanoma of the skin represents 5.2% of all new cancer cases in the U.S.

5.2%

In 2022, it is estimated that there will be 99,780 new cases of melanoma of the skin and an estimated 7,650 people will die of this disease.

Who Gets This Cancer?

Melanoma is more common in men than women and among individuals of fair complexion and those who have been exposed to natural or artificial sunlight (such as tanning beds) over long periods of time. There are more new cases among whites than any other racial/ethnic group. The rate of new cases of melanoma of the skin was 21.5 per 100,000 men and women per year based on 2015–2019 cases, age-adjusted.

Rate of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Melanoma of the Skin
Males
All Races 27.6
Non-Hispanic White 38.6
Non-Hispanic Black 1.0
Non-Hispanic Asian/Pacific Islander 1.4
Non-Hispanic American Indian/Alaska Native 8.7
Hispanic 4.6
Females
All Races 17.0
Non-Hispanic White 25.5
Non-Hispanic Black 0.9
Non-Hispanic Asian/Pacific Islander 1.2
Non-Hispanic American Indian/Alaska Native 8.3
Hispanic 4.5

SEER 22 2015–2019, Age-Adjusted

Percent of New Cases by Age Group: Melanoma of the Skin
Age Range Percent of New Cases
<20 0.3%
20–34 4.8%
35–44 7.1%
45–54 13.1%
55–64 22.4%
65–74 25.8%
75–84 18.0%
>84 8.5%

Melanoma of the skin is most frequently diagnosed among people aged 65–74.

Median Age
At Diagnosis

65

SEER 22 2015–2019, All Races, Both Sexes

Who Dies From This Cancer?

For melanoma of the skin, death rates are higher among the middle-aged and elderly. The death rate was 2.1 per 100,000 men and women per year based on 2016–2020 deaths, age-adjusted.

Death Rate per 100,000 Persons by Race/Ethnicity & Sex: Melanoma of the Skin
Males
All Races 3.1
Non-Hispanic White 3.9
Non-Hispanic Black 0.3
Non-Hispanic Asian/Pacific Islander 0.4
Non-Hispanic American Indian/Alaska Native 1.2
Hispanic 0.9
Females
All Races 1.3
Non-Hispanic White 1.7
Non-Hispanic Black 0.3
Non-Hispanic Asian/Pacific Islander 0.3
Non-Hispanic American Indian/Alaska Native 0.6
Hispanic 0.5

U.S. 2016–2020, Age-Adjusted

Percent of Deaths by Age Group: Melanoma of the Skin
Age Range Percent of Deaths
<20 0.1%
20–34 1.6%
35–44 3.8%
45–54 8.4%
55–64 18.2%
65–74 25.3%
75–84 24.7%
>84 17.9%

The percent of melanoma of the skin deaths is highest among people aged 65–74.

Median Age
At Death

72

U.S. 2016–2020, All Races, Both Sexes

Trends in Rates

Changes Over Time

Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, age-adjusted rates for new melanoma of the skin cases have been rising on average 1.2% each year over 2010–2019. Age-adjusted death rates have been falling on average 3.3% each year over 2011–2020. 5-year relative survival trends are shown below.

Interactive Statistics with SEER*Explorer

With SEER*Explorer, you can...
  • Create custom graphs and tables
  • Download data and images
  • Share links to results

SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.

Explore Additional Melanoma of the Skin Statistics

More About This Cancer

Melanoma

Figure: Melanoma Anatomy

Figure: Anatomy of the skin, showing the epidermis, dermis, and subcutaneous tissue. Melanocytes are in the layer of basal cells at the deepest part of the epidermis.

Skin cancer can occur anywhere on the body, but it is most common in skin that is often exposed to sunlight, such as the face, neck, hands, and arms. There are different types of cancer that start in the skin.

Melanoma is a disease in which malignant (cancer) cells form in the skin cells called melanocytes (cells that color the skin). Melanocytes are found throughout the lower part of the epidermis. They make melanin, the pigment that gives skin its natural color.

Additional Information

More Information

Here are some resources for learning more about melanoma of the skin.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Melanoma of the Skin. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/melan.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.

Estimates of new cases and deaths for 2022 are projections made by the American Cancer Society (ACS), based on earlier reported data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.